Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Inflammation × Pioglitazone × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 8 Insulin Resistance 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Diabetes Mellitus, Type 2 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Leukemia, Myeloid, Chronic-Phase 2 Carotid Intimal Medial Thickness 1 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Sleep Apnea, Obstructive 1 Skin Neoplasms 1 Recurrence 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Metabolic Syndrome 1 Meningioma 1 Memory Disorders 1 Lung Neoplasms 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Inflammation 1 Hyperinsulinism 1 Glucose Intolerance 1 Glioblastoma 1 Cognitive Dysfunction 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Exercise 3 salicylsalicylic acid 2 palbociclib 2 Vitamin D 2 Tea 2 Tablets 2 Sufentanil 2 Spironolactone 2 Resistance Training 2 Oxycodone 2 Omeprazole 2 Nutrition Assessment 2 Metformin 2 Ketorolac 2 Ibuprofen 2 Fish Oils 2 Blood Specimen Collection 2 Ascorbic Acid 2 ziprasidone 1 soybean oil, phospholipid emulsion 1 semaglutide 1 montelukast 1 microcrystalline cellulose 1 ginger extract 1 falcarinol 1 falcarindiol 1 epigallocatechin gallate 1 dapagliflozin 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Zolpidem 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02689843 2019-11-12

AntiPCO

Shiraz University of Medical Sciences

Phase EARLY_PHASE1 Completed

Inflammation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡